ENDOD1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to ENDOD1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency	PHASE2/PHASE3	RECRUITING
EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients	PHASE2	COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma	PHASE1/PHASE2	COMPLETED
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer	PHASE2	COMPLETED
Satraplatin and Prednisone to Treat Prostate Cancer	PHASE2	COMPLETED
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors	PHASE1	COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors	PHASE1	COMPLETED
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers	PHASE1	COMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve	nan	UNKNOWN
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.	nan	UNKNOWN
PCD New Gene Discovery	nan	COMPLETED
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients	nan	COMPLETED
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)	nan	RECRUITING
DNA Damage & Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease	nan	COMPLETED
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients	nan	UNKNOWN
Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome	nan	COMPLETED
Impact of Elastin Mediated Vascular Stiffness on End Organs	nan	COMPLETED
Genetic Characterization of Parkinson's Disease	nan	COMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic	nan	COMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome	nan	UNKNOWN
Genetics of Primary Ciliary Dyskinesia	nan	COMPLETED
Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery	nan	COMPLETED
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations	nan	COMPLETED
Apoptosis Markers in Aggressive Periodontitis	nan	COMPLETED
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank	nan	COMPLETED
Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study Micro AAA	nan	UNKNOWN
Human Epididymis Protein 4 in Endometrial Carcinoma	nan	COMPLETED
Expression of TET1 Gene in Acute Leukaemia	nan	UNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing	nan	RECRUITING
Screening of Lysosomal Storage Disorders Diseases in Minority Groups	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a ENDOD1 binder may also engage these)

Protein	Name	Similarity
Q8C522	—	1.000	Q8C522 →
P78363	—	0.986	P78363 →
Q95JR7	—	0.983	Q95JR7 →
Q3TT99	—	0.983	Q3TT99 →
P35054	—	0.983	P35054 →
Q9ESR9	—	0.983	Q9ESR9 →
Q9BX74	—	0.983	Q9BX74 →
Q6W3E5	—	0.983	Q6W3E5 →
Q9EPR2	—	0.982	Q9EPR2 →
Q4VSN4	—	0.982	Q4VSN4 →
O95477	—	0.982	O95477 →
Q9BZC7	—	0.982	Q9BZC7 →
Q9R097	—	0.982	Q9R097 →
O35600	—	0.982	O35600 →
F1MWM0	—	0.982	F1MWM0 →
P0DP43	—	0.981	P0DP43 →
Q1KLX6	—	0.981	Q1KLX6 →
P30438	—	0.981	P30438 →
Q5PQL7	—	0.981	Q5PQL7 →
Q6XUX1	—	0.981	Q6XUX1 →
Q1KLY5	—	0.981	Q1KLY5 →
Q63691	—	0.980	Q63691 →
Q95JI2	—	0.980	Q95JI2 →
Q9D9J7	—	0.980	Q9D9J7 →
TRPV1	Transient receptor potential cation channel subfamily V member 1	0.980	landscape →
P41233	—	0.980	P41233 →
Q1KLY7	—	0.980	Q1KLY7 →
P58239	—	0.980	P58239 →
Q7TNI2	—	0.980	Q7TNI2 →
Q4TVR5	—	0.980	Q4TVR5 →